Expansion into international markets such as Latin America, Asia Pacific, and underpenetrated regions like China—where differentiated technology, low market share, and a large runway for immunoassay growth exist—positions QuidelOrtho to capture increased demand stemming from global health system focus on early detection and public health surveillance. This is expected to drive topline revenue growth.